Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Orange Park › NPI 1689611501
Hospital

Orange Park Medical Center, INC.

Orange Park Medical Center, INC. was paid $28.68M by Medicaid between Jan 2018 and Dec 2024, across 195 billing codes. Its largest line is 99283, emergency room visit (moderate) — 41% of everything it billed.

33Billing provider infoORANGE PARK MEDICAL CENTER, INC.
ORANGE PARK, FL 32073
33aNPI1689611501assigned 05/31/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$28.68M
24GClaims779,791
24DCodes billed195
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Florida

Rank by total paid#6 of 163
Median peer was paid$4.77M
This provider vs. median6.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201857,273$758K
2019151,168$4.14M
2020134,167$3.91M
2021150,436$5.33M
2022154,667$6.34M
202389,105$4.97M
2024incomplete42,975$3.23M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 41% 135,699 124,303 $11.67M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 16% 58,191 50,775 $4.54M
99282 Emergency department visit for the evaluation and management, low to moderate severity 7.6% 26,163 24,732 $2.17M
99281 Emergency department visit for the evaluation and management, self-limited or minor 3.8% 10,676 10,090 $1.10M
80053 Comprehensive metabolic panel 2.7% 20,234 16,876 $785K
70450 Computed tomography, head or brain; without contrast material 2.6% 6,426 5,507 $753K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.3% 4,639 4,208 $662K
80048 Basic metabolic panel (calcium, ionized) 2.1% 14,378 11,693 $610K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 2.1% 7,962 6,739 $599K
71275 Computed tomographic angiography, chest, with contrast material 1.4% 2,219 1,982 $399K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.3% 2,603 2,362 $379K
10060 1.0% 1,879 1,761 $289K
183 more codes
81003 <1% 29,642 $262K
59025 Fetal non-stress test <1% 5,115 $238K
84702 <1% 4,643 $217K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 4,852 $198K
76818 <1% 2,670 $172K
71046 Radiologic examination, chest; 2 views <1% 13,460 $164K
96361 Intravenous infusion, hydration; each additional hour <1% 1,423 $143K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 1,882 $132K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 1,597 $131K
12001 <1% 1,103 $129K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 2,241 $123K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 10,883 $106K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 2,718 $101K
81001 <1% 8,826 $98K
87210 <1% 6,008 $97K
87070 <1% 3,973 $95K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 12,779 $93K
86850 <1% 1,116 $86K
36415 Collection of venous blood by venipuncture <1% 3,332 $85K
85027 <1% 37,165 $84K
12011 <1% 796 $83K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 2,345 $78K
81025 <1% 30,516 $75K
84112 <1% 529 $74K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 2,169 $73K
87430 <1% 8,101 $61K
80305 <1% 2,194 $61K
G0378 Hospital observation service, per hour <1% 4,485 $60K
72125 Computed tomography, cervical spine; without contrast material <1% 2,285 $56K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 20,976 $56K
73610 <1% 1,946 $55K
73130 <1% 1,871 $53K
71045 Radiologic examination, chest; single view <1% 10,079 $50K
73630 <1% 2,089 $48K
82565 <1% 674 $48K
A9270 Non-covered item or service <1% 11,551 $45K
73564 <1% 1,799 $44K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 8,279 $43K
76801 <1% 3,908 $42K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 5,326 $41K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,946 $39K
12002 <1% 364 $39K
73030 <1% 1,594 $32K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 17,347 $31K
87077 <1% 1,842 $29K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,450 $28K
93976 <1% 1,328 $25K
73110 <1% 845 $23K
70486 <1% 297 $23K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 8,415 $23K
74018 <1% 886 $20K
93971 <1% 1,298 $19K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 3,464 $19K
71250 <1% 237 $19K
76830 Ultrasound, transvaginal <1% 1,770 $18K
84484 <1% 10,347 $18K
85610 <1% 3,245 $18K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,002 $16K
72131 <1% 361 $16K
J1644 Injection, heparin sodium, per 1000 units <1% 1,626 $16K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 199 $15K
85730 <1% 2,693 $15K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 201 $15K
84703 <1% 2,589 $14K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 14,419 $12K
73140 <1% 160 $11K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 2,954 $11K
87807 <1% 1,487 $10K
86900 <1% 1,762 $10K
C1769 Guide wire <1% 288 $10K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 132 $10K
85014 <1% 849 $9K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,079 $9K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 507 $8K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 44 $8K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,455 $7K
85379 <1% 1,473 $7K
73590 <1% 321 $7K
J7030 Infusion, normal saline solution , 1000 cc <1% 8,250 $7K
86901 <1% 2,608 $6K
80047 <1% 151 $6K
73090 <1% 218 $6K
80076 <1% 1,265 $5K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 5,856 $5K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 7,792 $5K
73560 <1% 184 $5K
73502 <1% 341 $5K
64400 <1% 15 $5K
83880 <1% 1,746 $4K
73080 <1% 161 $4K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 278 $4K
96375 Therapeutic injection; each additional sequential IV push <1% 7,654 $3K
82550 <1% 1,458 $3K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 8,611 $3K
29125 <1% 303 $3K
84443 Thyroid stimulating hormone (TSH) <1% 2,418 $3K
73620 <1% 94 $3K
83735 <1% 2,771 $3K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 1,587 $3K
83690 <1% 8,685 $3K
80061 Lipid panel <1% 1,165 $3K
J7120 Ringers lactate infusion, up to 1000 cc <1% 6,538 $3K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,341 $3K
72100 <1% 192 $2K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 5,837 $2K
97162 <1% 60 $2K
73100 <1% 65 $2K
J1650 Injection, enoxaparin sodium, 10 mg <1% 1,003 $2K
87205 <1% 74 $2K
87040 <1% 1,677 $2K
J3490 Unclassified drugs <1% 17 $2K
81015 <1% 119 $2K
J1815 Injection, insulin, per 5 units <1% 1,067 $2K
29515 <1% 29 $2K
93017 <1% 90 $2K
83605 <1% 1,858 $2K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 84 $2K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 21 $2K
70551 Magnetic resonance imaging, brain; without contrast material <1% 17 $2K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 2,370 $1K
69200 <1% 14 $1K
77067 Screening mammography, bilateral, including computer-aided detection <1% 54 $1K
J2270 Injection, morphine sulfate, up to 10 mg <1% 5,449 $1K
73700 <1% 14 $1K
76775 <1% 16 $1K
85018 <1% 1,021 $1K
90714 <1% 1,501 $1K
93970 <1% 142 $936.03
83036 Hemoglobin; glycosylated (A1C) <1% 480 $826.98
84100 <1% 1,281 $826.82
84439 <1% 190 $762.74
72128 <1% 13 $642.53
80329 <1% 671 $599.31
80320 <1% 794 $548.92
J2060 Injection, lorazepam, 2 mg <1% 1,460 $546.25
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 28 $535.35
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,590 $483.86
72141 <1% 15 $458.16
72110 <1% 25 $416.11
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,331 $414.17
J2550 Injection, promethazine hcl, up to 50 mg <1% 1,664 $378.79
83615 <1% 267 $362.26
82248 <1% 489 $360.92
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 586 $345.50
76870 <1% 12 $307.71
82247 <1% 51 $288.72
84520 <1% 304 $280.13
87186 <1% 1,708 $222.60
J8540 Dexamethasone, oral, 0.25 mg <1% 1,234 $172.02
J0690 Injection, cefazolin sodium, 500 mg <1% 286 $171.66
86308 <1% 15 $164.26
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 293 $159.96
76820 <1% 234 $157.84
J7050 Infusion, normal saline solution, 250 cc <1% 84 $156.30
96376 <1% 1,219 $155.55
97163 <1% 14 $154.56
G1003 Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program <1% 252 $146.75
84550 <1% 272 $134.04
82607 <1% 37 $120.00
82746 <1% 37 $120.00
86140 <1% 198 $113.71
81002 <1% 33 $80.00
73120 <1% 29 $39.44
82570 <1% 96 $23.55
85652 <1% 46 $8.76
J1630 Injection, haloperidol, up to 5 mg <1% 175 $7.40
77063 Screening digital breast tomosynthesis, bilateral 0% 36 $0.00
82077 0% 32 $0.00
J0360 Injection, hydralazine hcl, up to 20 mg 0% 45 $0.00
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml 0% 12 $0.00
41899 Unlisted procedure, dentoalveolar structures 0% 77 $0.00
84450 0% 105 $0.00
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) 0% 3,613 $0.00
82010 0% 39 $0.00
84460 0% 106 $0.00
00170 Anesthesia for intraoral procedures, including biopsy 0% 60 $0.00
J3370 Injection, vancomycin hcl, 500 mg 0% 17 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 0% 76 $0.00
73070 0% 25 $0.00
Q0177 Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 0% 12 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 12 $0.00
82977 0% 18 $0.00
85048 0% 21 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPETTUS, JAY (CFO)